CD19 and acute lymphoblastic leukemia: To generate B-ALL cell lines resistant to anti-CD19–based immunotherapy, parental cells of the NALM6 and REH cell lines were grown in the presence of HD37-dgRTA immunotoxin (11) at increasing concentrations over 30 days (Figure 1A).